Poly(2-oxazoline)-protein conjugates

被引：37
作者：
Sedlacek, Ondrej [1 ]
de la Rosa, Victor R. [1 ]
Hoogenboom, Richard [1 ]
机构：
[1] Univ Ghent, Ctr Macromol Chem CMaC, Dept Organ & Macromol Chem, Supramol Chem Grp, Krijgslaan 281 S4, B-9000 Ghent, Belgium
来源：
EUROPEAN POLYMER JOURNAL | 2019年 / 120卷
关键词：
Bioconjugates; Polyoxazoline-peptide conjugates; Polyoxazoline-protein conjugates; IN-VITRO; FUNCTIONALIZED POLY(2-OXAZOLINE)S; BLOCK-COPOLYMERS; DRUG; POLY(2-ETHYL-2-OXAZOLINE); NANOPARTICLES; PEG; DIHYDROXYLATION; BIODISTRIBUTION; POXYLATION;
D O I：
10.1016/j.eurpolymj.2019.109246
中图分类号：
O63 [高分子化学（高聚物）];
学科分类号：
070305 ; 080501 ; 081704 ;
摘要：
Poly(2-oxazoline)s (in literature abbreviated as PAOx, POx, or POZ, herein referred to as PAOx) represent an emerging class of biocompatible polymers outperforming polyethylene glycol (PEG) in many aspects, including their high synthetic versatility and structural modularity. In this review, we provide a brief introduction to PAOx chemistry and biology to sketch their potential in biomaterials science. Further, we provide a detailed comprehensive overview of the literature on PAOx-protein conjugates with emphasis on their critical evaluation and comparison with analogous systems based on PEG. Based on this literature overview, PAOx seem to be an excellent alternative to PEG in the construction of therapeutic polymer-protein conjugates.
引用
收藏
页数：7
相关论文
共 83 条
  • [1] Maleimide end-functionalized poly(2-oxazoline)s by the functional initiator route: synthesis and (bio) conjugation
    Alvaradejo, Gabriela Gil
    Glassner, Mathias
    Hoogenboom, Richard
    Delaittre, Guillaume
    [J]. RSC ADVANCES, 2018, 8 (17): : 9471 - 9479
  • [2] [Anonymous], 2017, POLYM BIOMEDICINE SY
  • [3] [Anonymous], POLYM BIOMEDICINE SY
  • [4] Polymerization of oxazolines
    Aoi, K
    Okada, M
    [J]. PROGRESS IN POLYMER SCIENCE, 1996, 21 (01) : 151 - 208
  • [5] Bauer M., 2013, J POLYM SCI A, V51, P2113
  • [6] Poly(2-ethyl-2-oxazoline) as Alternative for the Stealth Polymer Poly(ethylene glycol): Comparison of in vitro Cytotoxicity and Hemocompatibility
    Bauer, Marius
    Lautenschlaeger, Christian
    Kempe, Kristian
    Tauhardt, Lutz
    Schubert, Ulrich S.
    Fischer, Dagmar
    [J]. MACROMOLECULAR BIOSCIENCE, 2012, 12 (07) : 986 - 998
  • [7] Pharmacokinetics, metabolism and distribution of PEGs and PEGylated proteins: quo vadis?
    Baumann, Andreas
    Tuerck, Dietrich
    Prabhu, Saileta
    Dickmann, Leslie
    Sims, Jennifer
    [J]. DRUG DISCOVERY TODAY, 2014, 19 (10) : 1623 - 1631
  • [8] POxylation as an alternative stealth coating for biomedical applications
    Bludau, Herdis
    Czapar, Anna E.
    Pitek, Andrzej S.
    Shukla, Sourabh
    Jordan, Rainer
    Steinmetz, Nicole F.
    [J]. EUROPEAN POLYMER JOURNAL, 2017, 88 : 679 - 688
  • [9] Caliceti P., 2003, ADV DRUG DEL REV, V55, P1529
  • [10] Cegtowski M., 2015, MACROMOLECULES, V51, P69
123456789